Home/Pipeline/Gene Therapy for Sporadic ALS

Gene Therapy for Sporadic ALS

Amyotrophic Lateral Sclerosis (Sporadic)

PreclinicalResearch

Key Facts

Indication
Amyotrophic Lateral Sclerosis (Sporadic)
Phase
Preclinical
Status
Research
Company

About Onodera

Japanese gene therapy biotech developing AAV-based treatments for neurodegenerative diseases like ALS and Parkinson's.

View full company profile

Therapeutic Areas